Comparative Efficacy of Cemiplimab to Historical Standard of Care in France

Clinical trial NCT05302297 · COMPLETED

Trial details

NCT number: NCT05302297
Sponsor: Sanofi
Status: COMPLETED
Study type: OBSERVATIONAL

Cancer/Squamous Cell Carcinoma of Skin

Start date: 2022-01-17
Primary completion: 2022-09-30
Enrollment: 305

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.